AYTU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aytu Biopharma Inc

Watchlist Manager

Watchlist

Price: 2.08 USD -5.45% Market Closed

Market Cap: $22.3m

	Aytu Biopharma Inc NASDAQ:AYTU	US
G	Grahaprima Suksesmandiri Tbk PT IDX:GTRA	ID
	One Stop Systems Inc NASDAQ:OSS	US
H	Hawaiian Electric Industries Inc F:HWI	US
J	Jocil Ltd NSE:JOCIL	IN
	Bengal Energy Ltd TSX:BNG	CA
	Public Storage NYSE:PSA	US
	Liontown Resources Ltd ASX:LTR	AU

Profitability Summary

Aytu Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

67%

Gross Margin is Increasing

60% > 67%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-20% > -1%

Negative Net Margin

-39%

Negative 3Y Average Net Margin

-17%

Declining Net Margin

-29% > -39%

Negative Free Cash Flow Margin

-6%

Negative 3Y Average Free Cash Flow Margin

-2%

Free Cash Flow Margin is Increasing

-21% > -6%

Negative ROE

-109%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-3%

ROIC is Increasing

-19% > -1%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.